Literature DB >> 18022245

Role of chemical structure in stereoselective recognition of beta-blockers by cyclodextrins in capillary zone electrophoresis.

László Gagyi1, Arpád Gyéresi, Ferenc Kilár.   

Abstract

Most of the beta-blocking drugs for treating diseases of the cardiovascular system are chiral aryloxy-propanolamine derivatives. Tipically, the S(-) enantiomers are more active than the R(+) enantiomers. Only some of them (for example timolol) are used as single enantiomers, the others are employed as racemates. For the determination of the enantiomeric purity of timolol European Pharmacopoeia prescribes an HPLC method using chiral stationary phase. However, the use of chiral capillary zone electrophoresis for the determination of the enantiomeric purity is of pharmaceutical interest. This study describes the application of various cyclodextrin derivatives, hydroxypropyl-beta-cyclodextrin, randomly methylated beta-cyclodextrin, sulphated beta-cyclodextrin and sulphated alpha-cyclodextrin for the stereoselective analyses of beta-blockers. Baseline separation was obtained for bopindolol, carvedilol, mepindolol, pindolol and alprenolol, while only partial separation was observed for sotalol, propranolol, oxprenolol, atenolol, bisoprolol, bupranolol, and metoprolol. The uneven molecular recognition of the enantiomers of the beta-blockers, especially of the optical isomers of labetalol and nadolol, showed the importance of the chemical nature of the separators and the analytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18022245     DOI: 10.1016/j.jbbm.2007.10.004

Source DB:  PubMed          Journal:  J Biochem Biophys Methods        ISSN: 0165-022X


  3 in total

1.  Metabolomic profiling of cellular responses to carvedilol enantiomers in vascular smooth muscle cells.

Authors:  Mingxuan Wang; Jing Bai; Wei Ning Chen; Chi Bun Ching
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

2.  Cyclodextrine screening for the chiral separation of carvedilol by capillary electrophoresis.

Authors:  Gabriel Hancu; Anca Cârje; Ileana Iuga; Ibolya Fülöp; Zoltán-István Szabó
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

3.  Enantioselective Resolution of (R,S)-Carvedilol to (S)-(-)-Carvedilol by Biocatalysts.

Authors:  Swetha Ettireddy; Vijitha Chandupatla; Ciddi Veeresham
Journal:  Nat Prod Bioprospect       Date:  2017-01-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.